Refresh

Solvay Pharma India Ltd.[Amalgamated] - Research Center

532447 DUPHARPH Group (N.A.) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Dec ' 10 Jun ' 10 Dec ' 09 Jun ' 09 Dec ' 08

Sales

160.22 136.69 130.80 115.71 103.55

Operating profit

35.24 40.13 32.77 28.86 24.90

Interest

- - - - 0.01

Gross profit

37.37 41.68 34.27 29.70 26.28

EPS (Rs)

47.81 52.89 43.02 36.25 32.86
Half yearly  results in details
Dec ' 10 Jun ' 10 Dec ' 09 Jun ' 09 Dec ' 08

Other income

2.13 1.55 1.50 0.84 1.39

Stock adjustment

5.08 -4.35 0.91 1.29 -6.55

Raw material

25.76 28.71 27.06 22.73 25.39

Power and fuel

- - - - -

Employee expenses

19.26 14.47 14.20 12.27 10.74

Excise

- - - 3.36 -7.14

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

74.88 57.74 55.86 47.21 56.20

Provisions made

- - - - -

Depreciation

1.62 1.58 2.06 1.25 0.60

Taxation

11.61 13.39 10.48 10.15 9.08

Net profit / loss

24.14 26.71 21.73 18.30 16.59

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

5.05 5.05 5.05 5.05 5.05

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

5.63 5.63 15.73 15.73 15.73

Agg.of non promotoholding (%)

11.15 11.15 31.15 31.15 31.15

OPM (%)

21.99 29.36 25.06 24.94 24.05

GPM (%)

23.02 30.15 25.90 25.48 25.04

NPM (%)

14.87 19.32 16.42 15.70 15.81
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com